Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

This is the article, right?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
apostrophe Member Profile
 
Followed By 19
Posts 1,084
Boards Moderated 0
Alias Born 10/17/06
160x600 placeholder
BTIG Remains a Buy on Anavex Life Sciences (AVXL) TipRanks - 1/19/2022 1:45:28 AM
Anavex Life Sciences (AVXL) Gets a Buy Rating from H.C. Wainwright TipRanks - 1/11/2022 6:45:12 AM
JonesTrading Reaffirms Their Buy Rating on Anavex Life Sciences (AVXL) TipRanks - 1/10/2022 12:55:34 PM
Anavex Life Sciences Reports Positive Results from Phase 1 Clinical Trial of ANAVEX®3-71 GlobeNewswire Inc. - 1/10/2022 7:00:00 AM
Anavex Life Sciences Promotes Walter E Kaufmann, M.D. to Chief Scientific Officer and Appoints Edward R Hammond, M.D., M.P.H., Ph.D., as Chief Medical Officer GlobeNewswire Inc. - 1/6/2022 7:00:00 AM
Anavex Life Sciences Updates 2 Key Risk Factors TipRanks - 1/6/2022 6:01:37 AM
Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference GlobeNewswire Inc. - 1/5/2022 7:00:00 AM
Dawson James Maintains a Buy Rating on Anavex Life Sciences (AVXL) TipRanks - 1/5/2022 4:10:29 AM
Anavex Life Sciences to Present at 40th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 12/14/2021 7:00:00 AM
Anavex Life Sciences to Present at the 4th Annual Evercore ISI HealthCONx Conference GlobeNewswire Inc. - 11/29/2021 7:00:00 AM
Anavex Life provides key updates on clinical trials in rare genetic neurological disorders Seeking Alpha - 11/24/2021 9:40:36 AM
Anavex Life Sciences EPS misses by $0.39 Seeking Alpha - 11/24/2021 7:07:01 AM
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results GlobeNewswire Inc. - 11/24/2021 7:00:00 AM
Notable earnings after Wednesday's close Seeking Alpha - 11/23/2021 5:35:23 PM
Anavex Life Sciences FY 2021 Earnings Preview Seeking Alpha - 11/23/2021 1:20:23 PM
Notable earnings before Wednesday's open Seeking Alpha - 11/23/2021 10:42:34 AM
Anavex Life Sciences to Announce Fiscal 2021 Year End Financial Results on Wednesday, November 24, 2021 GlobeNewswire Inc. - 11/17/2021 7:00:00 AM
Anavex Life Sciences Announces Participation at Upcoming Lausanne VIII Workshop Panel - Building Global Momentum for Interventions in Alzheimer’s Disease GlobeNewswire Inc. - 11/10/2021 7:00:00 AM
Anavex Life Sciences to Present at the Dawson James Securities 6th Annual Conference GlobeNewswire Inc. - 10/15/2021 7:00:00 AM
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX®2-73 in Patients with Alzheimer’s Disease GlobeNewswire Inc. - 10/13/2021 7:00:00 AM
Cassava down after phase 3 simufilam announcement; other Alzheimer's names follow Seeking Alpha - 10/6/2021 12:51:22 PM
CEO Presenting on the Emerging Growth Conference on September 29  Register Now InvestorsHub NewsWire - 9/28/2021 8:00:00 AM
Anavex Life Sciences Announces Participation at 5th Pharma Pricing, Reimbursement & Market Access 2021 GlobeNewswire Inc. - 9/27/2021 9:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2021 8:11:01 AM
Anavex Life Sciences Announces Uplisting to the NASDAQ Global Select Market® GlobeNewswire Inc. - 9/27/2021 7:00:00 AM
apostrophe   Saturday, 05/14/16 06:02:29 AM
Re: TrueTrades post# 62758
Post # of 347047 
This is the article, right?

http://www.fool.com/investing/general/2016/05/13/5-key-takeaways-from-anavex-life-sciences-second-q.aspx?source=iaasitlnk0000003

His attempt to conflagrate a miniscule 3% increase in share count over last year into "OMG 3% ! Run fer the hills! Your stake is dwindling into nothing! Oh yes. Investors are furious! Furious I tell yah! Woop woop woop!"

This reminds me of articles on financial media outlets market watch which seem to be written ahead of time with blanks to be filled in later with anticipated results e.g. "The price of gold plummeted in overnight markets by __ -0.03% __ (huh?)

I've been in companies that dilute. Mining start-ups tend to dilate a lot. Like 100%. This is negligable. "Dwindle"? Oh Puh-leeeez! This is so minimal it should be considered a positive.

Then the obligatory sneer at the Lincoln Park backup option, by which choice of the term "interesting" is a veiled insinuation that it must be the typical toxic finance component that infests all those tacky little OTC companies that litter the landscape like shells of rotting shrimp carcasses. He pointedly ignores that the deal has a lot of protections built in. It won't trigger the sort of unlimitted share dumping by colluding insiders and loan sharks that occurs with the sort of scam operations that the author attempts to color AVXL as with his broad brush. Scam companies that also rack up huge corporate debt.

His next logical "key take-away" then, should be the topic of debt. One might get the impression from his prose that the $60M available from Lincoln is all but spent. But, in fact, it hasn't been utilized. So where is his topic section examining the huge millions and millions of crushing debt that typically overhangs investors in small developmental bio-tech companies? He seems to have skipped it. Maybe because, guess what? Anavex has no debt. No debt. Isn't that kind of an important key point to completely leave out?

The prefabricated ignorance being propagated in this sorry excuse for an article is indeed infuriating.




Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences